Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 01 08 2018
revised: 30 11 2018
accepted: 16 12 2018
pubmed: 29 12 2018
medline: 14 6 2019
entrez: 29 12 2018
Statut: ppublish

Résumé

The recent 2017 modification have increased the sensitivity of McDonald criteria for MS. Nevertheless, some MS patients with atypical MRI findings have been identified, leading to prolonged delay to diagnosis and high costs to look for alternative diagnoses. To describe a series of MS patients with atypical MRI presentation. Patients with atypical MS were identified through a nationwide retrospective study. We established a five groups classification: tumefactive demyelinating lesion (TDL)-onset MS, acute disseminated encephalomyelitis (ADEM)-like MS, cavitary MS and leukodystrophy-like MS. All the patients meeting our radiological criteria for atypical MS were included. A total of 57 patients met the inclusion criteria. 7 cases were classified in the TDL-onset group, 10 in the ADEM-like group, 26 in the cavitary group and 14 in the leukodystrophy-like group. Overall risk of conversion to MS after an isolated TDL was around 30% at five years. Patients in the TDL-onset and ADEM-like groups globally presented an acute onset and a relapsing-remitting evolution. Conversely, patients in the cavitary and leukodystrophy- groups largely evolved with a progressive and severe course. A significant number of MS patients can have a striking atypical presentation and may be misdiagnosed. This preliminary analysis helps to refine the spectrum of atypical MS patients.

Sections du résumé

BACKGROUND BACKGROUND
The recent 2017 modification have increased the sensitivity of McDonald criteria for MS. Nevertheless, some MS patients with atypical MRI findings have been identified, leading to prolonged delay to diagnosis and high costs to look for alternative diagnoses.
OBJECTIVE OBJECTIVE
To describe a series of MS patients with atypical MRI presentation.
MATERIAL AND METHODS METHODS
Patients with atypical MS were identified through a nationwide retrospective study. We established a five groups classification: tumefactive demyelinating lesion (TDL)-onset MS, acute disseminated encephalomyelitis (ADEM)-like MS, cavitary MS and leukodystrophy-like MS. All the patients meeting our radiological criteria for atypical MS were included.
RESULTS RESULTS
A total of 57 patients met the inclusion criteria. 7 cases were classified in the TDL-onset group, 10 in the ADEM-like group, 26 in the cavitary group and 14 in the leukodystrophy-like group. Overall risk of conversion to MS after an isolated TDL was around 30% at five years. Patients in the TDL-onset and ADEM-like groups globally presented an acute onset and a relapsing-remitting evolution. Conversely, patients in the cavitary and leukodystrophy- groups largely evolved with a progressive and severe course.
CONCLUSION CONCLUSIONS
A significant number of MS patients can have a striking atypical presentation and may be misdiagnosed. This preliminary analysis helps to refine the spectrum of atypical MS patients.

Identifiants

pubmed: 30592992
pii: S2211-0348(18)30554-6
doi: 10.1016/j.msard.2018.12.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-116

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Pekes Codjia (P)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France; MS, demyelinating and neuro-inflammatory diseases center, Department of Neurology, Lyon University Hospital, 69677 Lyon-Bron Cedex, France.

Xavier Ayrignac (X)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France.

Clarisse Carra-Dalliere (C)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France.

Mikael Cohen (M)

MS Clinic, Department of Neurology, Nice University Hospital, 06001 Nice, France.

Mahmoud Charif (M)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France.

Anais Lippi (A)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France.

Nicolas Collongues (N)

Inflammatory CNS diseases center, Department of Neurology, Strasbourg University Hospital, 67200 Strasbourg, France.

Lucas Corti (L)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France.

Jerome De Seze (J)

Inflammatory CNS diseases center, Department of Neurology, Strasbourg University Hospital, 67200 Strasbourg, France.

Christine Lebrun (C)

MS Clinic, Department of Neurology, Nice University Hospital, 06001 Nice, France.

Sandra Vukusic (S)

MS, demyelinating and neuro-inflammatory diseases center, Department of Neurology, Lyon University Hospital, 69677 Lyon-Bron Cedex, France.

Francoise Durand-Dubief (F)

MS, demyelinating and neuro-inflammatory diseases center, Department of Neurology, Lyon University Hospital, 69677 Lyon-Bron Cedex, France.

Pierre Labauge (P)

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France. Electronic address: labauge@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH